05-644
抗-CAR抗体，克隆RmcB
clone RmcB, Upstate®, from mouse
别名:
46 kD coxsackievirus and adenovirus receptor (CAR) protein, CVB3 binding protein, CVB3-binding protein, Coxsackievirus B-adenovirus receptor, coxsackie virus B receptor, coxsackie virus and adenovirus receptor
生物来源
mouse
质量水平
偶联物
unconjugated
抗体形式
purified immunoglobulin
抗体产品类型
primary antibodies
克隆
RmcB, monoclonal
种属反应性
human, rat, mouse
制造商/商品名称
Upstate®
技术
immunocytochemistry: suitable
western blot: suitable
同位素/亚型
IgG1
NCBI登记号
UniProt登记号
运输
wet ice
靶向翻译后修饰
unmodified
基因信息
human ... CXADR(1525)
一般描述
~46 kDa
柯萨奇病毒和腺病毒受体（CAR）介导柯萨奇B病毒和许多腺病毒的细胞附着和感染。CAR还介导同型细胞间相互作用。在极化的上皮细胞中，CAR与紧密连接紧密相关，在紧密连接中，CAR有助于溶质和大分子的细胞旁流动。CAR′s的生物学作用尚不明确，但新出现的证据表明它可能在胚胎发育和调节细胞增殖中起作用。
免疫原
天然人柯萨奇病毒-腺病毒受体蛋白。
应用
免疫细胞化学：
1-2 μg/mL先前批次在HeLa细胞，hCAR转染的CHO细胞中显示出CAR的阳性免疫染色，但在用4%多聚甲醛固定并用0.2%Triton-X透化的未转染的CHO细胞中则没有。
1-2 μg/mL先前批次在HeLa细胞，hCAR转染的CHO细胞中显示出CAR的阳性免疫染色，但在用4%多聚甲醛固定并用0.2%Triton-X透化的未转染的CHO细胞中则没有。
抗CAR抗体，克隆RmcB可检测CAR的水平 & 已出版 & 并经过验证可用于IC & WB。
生化/生理作用
识别分子量约为6 kDa的CAR。
外形
形式：纯化
纯化的小鼠单克隆IgG1，溶于含有0.1M Tris甘氨酸（pH 7.4）、0.15M NaCl、0.05％叠氮化钠的缓冲液中。
分析说明
已通过蛋白质印迹对小鼠小肠裂解液进行了评估。
蛋白质印迹分析：
该抗体的1：500的稀释液在10 µg小鼠小肠裂解液中检测到Car。
蛋白质印迹分析：
该抗体的1：500的稀释液在10 µg小鼠小肠裂解液中检测到Car。
其他说明
浓度：请参考批次特异性浓缩物的分析证书。
法律信息
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
储存分类代码
10 - Combustible liquids
WGK
WGK 1
William C Adams et al.
The Journal of general virology, 90(Pt 7), 1600-1610 (2009-03-14)
The coxsackievirus-adenovirus receptor (CAR) is the described primary receptor for adenovirus serotype 5 (Ad5), a common human pathogen that has been exploited as a viral vector for gene therapy and vaccination. This study showed that monocytes and dendritic cells (DCs)
Jeffrey E Teigler et al.
Journal of virology, 86(18), 9590-9598 (2012-07-13)
Adenovirus (Ad) vaccine vectors have proven highly immunogenic in multiple experimental models, but the innate immune responses induced by these vectors remain poorly characterized. Here we report innate cytokine responses to 5 different Ad vectors in 26 rhesus monkeys. Vaccination
Y Watanabe et al.
Cancer gene therapy, 19(11), 767-772 (2012-09-08)
Replication-selective oncolytic viruses are being developed for human cancer therapy. We previously developed an attenuated adenovirus (OBP-301, Telomelysin), in which the human telomerase reverse transcriptase promoter element drives expression of E1A and E1B genes linked with an internal ribosome entry
Sarah L Hulin-Curtis et al.
Oncotarget, 9(41), 26328-26341 (2018-06-15)
Ovarian cancer is often termed a silent killer due to the late onset of symptoms. Whilst patients initially respond to chemotherapy, they rapidly develop chemo-resistance. Oncolytic adenoviruses (OAds) are promising anti-cancer agents engineered to "hijack" the unique molecular machinery of
Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.
Zhai, Z; Wang, Z; Fu, S; Lu, J; Wang, F; Li, R; Zhang, H; Li, S; Hou, Z; Wang, H; Rodriguez, R
Gene Therapy null
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持